Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemoMouthpiece, LLC has developed the Chemo Mouthpiece®, an FDA-cleared intraoral cryotherapy device designed to reduce the frequency and severity of oral mucositis in patients undergoing chemotherapy. The product has demonstrated efficacy in reducing mouth sores and pain during clinical use and was studied in a multi-institutional randomized controlled trial. It received FDA Breakthrough Device Designation for its impact on chemotherapy-induced oral mucositis. Distribution partnerships are established for broad U.S. commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemo Mouthpiece.